img

Global Pet Skin Disease Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pet Skin Disease Drugs Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Pet Skin Disease Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pet Skin Disease Drugs market research.
Key manufacturers engaged in the Pet Skin Disease Drugs industry include Zoetis Animal Health, Boehringer Ingelheim, Elanco, Virbac, Norbrook Laboratories, Dechra Veterinary Products, Vetoquinol, ALKINLAB and Truseb, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Pet Skin Disease Drugs were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Pet Skin Disease Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pet Skin Disease Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Zoetis Animal Health
Boehringer Ingelheim
Elanco
Virbac
Norbrook Laboratories
Dechra Veterinary Products
Vetoquinol
ALKINLAB
Truseb
Olewo
KANGZHIBO
Shanghai Hanvet Bio-Pharm
DCVET
Nanjing LANBOTO
Jindun Pharmaceutical
Segment by Type
Internal Medication
External Medication

Segment by Application


Parasitic Skin Diseases
Fungal Dermatoses
Bacterial Skin Diseases
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pet Skin Disease Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Pet Skin Disease Drugs Market Overview
1.1 Product Overview and Scope of Pet Skin Disease Drugs
1.2 Pet Skin Disease Drugs Segment by Type
1.2.1 Global Pet Skin Disease Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Internal Medication
1.2.3 External Medication
1.3 Pet Skin Disease Drugs Segment by Application
1.3.1 Global Pet Skin Disease Drugs Market Value by Application: (2024-2034)
1.3.2 Parasitic Skin Diseases
1.3.3 Fungal Dermatoses
1.3.4 Bacterial Skin Diseases
1.3.5 Other
1.4 Global Pet Skin Disease Drugs Market Size Estimates and Forecasts
1.4.1 Global Pet Skin Disease Drugs Revenue 2018-2034
1.4.2 Global Pet Skin Disease Drugs Sales 2018-2034
1.4.3 Global Pet Skin Disease Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Pet Skin Disease Drugs Market Competition by Manufacturers
2.1 Global Pet Skin Disease Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pet Skin Disease Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pet Skin Disease Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Pet Skin Disease Drugs Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Pet Skin Disease Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Skin Disease Drugs, Product Type & Application
2.7 Pet Skin Disease Drugs Market Competitive Situation and Trends
2.7.1 Pet Skin Disease Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Skin Disease Drugs Players Market Share by Revenue
2.7.3 Global Pet Skin Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Skin Disease Drugs Retrospective Market Scenario by Region
3.1 Global Pet Skin Disease Drugs Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Pet Skin Disease Drugs Global Pet Skin Disease Drugs Sales by Region: 2018-2034
3.2.1 Global Pet Skin Disease Drugs Sales by Region: 2018-2023
3.2.2 Global Pet Skin Disease Drugs Sales by Region: 2024-2034
3.3 Global Pet Skin Disease Drugs Global Pet Skin Disease Drugs Revenue by Region: 2018-2034
3.3.1 Global Pet Skin Disease Drugs Revenue by Region: 2018-2023
3.3.2 Global Pet Skin Disease Drugs Revenue by Region: 2024-2034
3.4 North America Pet Skin Disease Drugs Market Facts & Figures by Country
3.4.1 North America Pet Skin Disease Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Pet Skin Disease Drugs Sales by Country (2018-2034)
3.4.3 North America Pet Skin Disease Drugs Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet Skin Disease Drugs Market Facts & Figures by Country
3.5.1 Europe Pet Skin Disease Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Pet Skin Disease Drugs Sales by Country (2018-2034)
3.5.3 Europe Pet Skin Disease Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Skin Disease Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Skin Disease Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Pet Skin Disease Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific Pet Skin Disease Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pet Skin Disease Drugs Market Facts & Figures by Country
3.7.1 Latin America Pet Skin Disease Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Pet Skin Disease Drugs Sales by Country (2018-2034)
3.7.3 Latin America Pet Skin Disease Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Skin Disease Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Skin Disease Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Pet Skin Disease Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa Pet Skin Disease Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet Skin Disease Drugs Sales by Type (2018-2034)
4.1.1 Global Pet Skin Disease Drugs Sales by Type (2018-2023)
4.1.2 Global Pet Skin Disease Drugs Sales by Type (2024-2034)
4.1.3 Global Pet Skin Disease Drugs Sales Market Share by Type (2018-2034)
4.2 Global Pet Skin Disease Drugs Revenue by Type (2018-2034)
4.2.1 Global Pet Skin Disease Drugs Revenue by Type (2018-2023)
4.2.2 Global Pet Skin Disease Drugs Revenue by Type (2024-2034)
4.2.3 Global Pet Skin Disease Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Pet Skin Disease Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global Pet Skin Disease Drugs Sales by Application (2018-2034)
5.1.1 Global Pet Skin Disease Drugs Sales by Application (2018-2023)
5.1.2 Global Pet Skin Disease Drugs Sales by Application (2024-2034)
5.1.3 Global Pet Skin Disease Drugs Sales Market Share by Application (2018-2034)
5.2 Global Pet Skin Disease Drugs Revenue by Application (2018-2034)
5.2.1 Global Pet Skin Disease Drugs Revenue by Application (2018-2023)
5.2.2 Global Pet Skin Disease Drugs Revenue by Application (2024-2034)
5.2.3 Global Pet Skin Disease Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Pet Skin Disease Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Zoetis Animal Health
6.1.1 Zoetis Animal Health Corporation Information
6.1.2 Zoetis Animal Health Description and Business Overview
6.1.3 Zoetis Animal Health Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Zoetis Animal Health Pet Skin Disease Drugs Product Portfolio
6.1.5 Zoetis Animal Health Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim Pet Skin Disease Drugs Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Elanco
6.3.1 Elanco Corporation Information
6.3.2 Elanco Description and Business Overview
6.3.3 Elanco Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Elanco Pet Skin Disease Drugs Product Portfolio
6.3.5 Elanco Recent Developments/Updates
6.4 Virbac
6.4.1 Virbac Corporation Information
6.4.2 Virbac Description and Business Overview
6.4.3 Virbac Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Virbac Pet Skin Disease Drugs Product Portfolio
6.4.5 Virbac Recent Developments/Updates
6.5 Norbrook Laboratories
6.5.1 Norbrook Laboratories Corporation Information
6.5.2 Norbrook Laboratories Description and Business Overview
6.5.3 Norbrook Laboratories Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Norbrook Laboratories Pet Skin Disease Drugs Product Portfolio
6.5.5 Norbrook Laboratories Recent Developments/Updates
6.6 Dechra Veterinary Products
6.6.1 Dechra Veterinary Products Corporation Information
6.6.2 Dechra Veterinary Products Description and Business Overview
6.6.3 Dechra Veterinary Products Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Dechra Veterinary Products Pet Skin Disease Drugs Product Portfolio
6.6.5 Dechra Veterinary Products Recent Developments/Updates
6.7 Vetoquinol
6.6.1 Vetoquinol Corporation Information
6.6.2 Vetoquinol Description and Business Overview
6.6.3 Vetoquinol Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Vetoquinol Pet Skin Disease Drugs Product Portfolio
6.7.5 Vetoquinol Recent Developments/Updates
6.8 ALKINLAB
6.8.1 ALKINLAB Corporation Information
6.8.2 ALKINLAB Description and Business Overview
6.8.3 ALKINLAB Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ALKINLAB Pet Skin Disease Drugs Product Portfolio
6.8.5 ALKINLAB Recent Developments/Updates
6.9 Truseb
6.9.1 Truseb Corporation Information
6.9.2 Truseb Description and Business Overview
6.9.3 Truseb Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Truseb Pet Skin Disease Drugs Product Portfolio
6.9.5 Truseb Recent Developments/Updates
6.10 Olewo
6.10.1 Olewo Corporation Information
6.10.2 Olewo Description and Business Overview
6.10.3 Olewo Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Olewo Pet Skin Disease Drugs Product Portfolio
6.10.5 Olewo Recent Developments/Updates
6.11 KANGZHIBO
6.11.1 KANGZHIBO Corporation Information
6.11.2 KANGZHIBO Pet Skin Disease Drugs Description and Business Overview
6.11.3 KANGZHIBO Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 KANGZHIBO Pet Skin Disease Drugs Product Portfolio
6.11.5 KANGZHIBO Recent Developments/Updates
6.12 Shanghai Hanvet Bio-Pharm
6.12.1 Shanghai Hanvet Bio-Pharm Corporation Information
6.12.2 Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Description and Business Overview
6.12.3 Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Product Portfolio
6.12.5 Shanghai Hanvet Bio-Pharm Recent Developments/Updates
6.13 DCVET
6.13.1 DCVET Corporation Information
6.13.2 DCVET Pet Skin Disease Drugs Description and Business Overview
6.13.3 DCVET Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 DCVET Pet Skin Disease Drugs Product Portfolio
6.13.5 DCVET Recent Developments/Updates
6.14 Nanjing LANBOTO
6.14.1 Nanjing LANBOTO Corporation Information
6.14.2 Nanjing LANBOTO Pet Skin Disease Drugs Description and Business Overview
6.14.3 Nanjing LANBOTO Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Nanjing LANBOTO Pet Skin Disease Drugs Product Portfolio
6.14.5 Nanjing LANBOTO Recent Developments/Updates
6.15 Jindun Pharmaceutical
6.15.1 Jindun Pharmaceutical Corporation Information
6.15.2 Jindun Pharmaceutical Pet Skin Disease Drugs Description and Business Overview
6.15.3 Jindun Pharmaceutical Pet Skin Disease Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Jindun Pharmaceutical Pet Skin Disease Drugs Product Portfolio
6.15.5 Jindun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Skin Disease Drugs Industry Chain Analysis
7.2 Pet Skin Disease Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Skin Disease Drugs Production Mode & Process
7.4 Pet Skin Disease Drugs Sales and Marketing
7.4.1 Pet Skin Disease Drugs Sales Channels
7.4.2 Pet Skin Disease Drugs Distributors
7.5 Pet Skin Disease Drugs Customers
8 Pet Skin Disease Drugs Market Dynamics
8.1 Pet Skin Disease Drugs Industry Trends
8.2 Pet Skin Disease Drugs Market Drivers
8.3 Pet Skin Disease Drugs Market Challenges
8.4 Pet Skin Disease Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pet Skin Disease Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Pet Skin Disease Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Pet Skin Disease Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pet Skin Disease Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Pet Skin Disease Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Pet Skin Disease Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Pet Skin Disease Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Pet Skin Disease Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Pet Skin Disease Drugs, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Pet Skin Disease Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pet Skin Disease Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Pet Skin Disease Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pet Skin Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Skin Disease Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pet Skin Disease Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Pet Skin Disease Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Pet Skin Disease Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Pet Skin Disease Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Pet Skin Disease Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Pet Skin Disease Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Pet Skin Disease Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Pet Skin Disease Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Pet Skin Disease Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Pet Skin Disease Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Pet Skin Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Pet Skin Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Pet Skin Disease Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Pet Skin Disease Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Pet Skin Disease Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Pet Skin Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Pet Skin Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Pet Skin Disease Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Pet Skin Disease Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Pet Skin Disease Drugs Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Pet Skin Disease Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Pet Skin Disease Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Pet Skin Disease Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Pet Skin Disease Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Pet Skin Disease Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Pet Skin Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Pet Skin Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Pet Skin Disease Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pet Skin Disease Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Pet Skin Disease Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Pet Skin Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Pet Skin Disease Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Pet Skin Disease Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Pet Skin Disease Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Pet Skin Disease Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Pet Skin Disease Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Pet Skin Disease Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Pet Skin Disease Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Pet Skin Disease Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Pet Skin Disease Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Pet Skin Disease Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Pet Skin Disease Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Pet Skin Disease Drugs Price (US$/Unit) by Type (2018-2023)
Table 59. Global Pet Skin Disease Drugs Price (US$/Unit) by Type (2024-2034)
Table 60. Global Pet Skin Disease Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Pet Skin Disease Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Pet Skin Disease Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Pet Skin Disease Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Pet Skin Disease Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Pet Skin Disease Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Pet Skin Disease Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Pet Skin Disease Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Pet Skin Disease Drugs Price (US$/Unit) by Application (2018-2023)
Table 69. Global Pet Skin Disease Drugs Price (US$/Unit) by Application (2024-2034)
Table 70. Zoetis Animal Health Corporation Information
Table 71. Zoetis Animal Health Description and Business Overview
Table 72. Zoetis Animal Health Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Zoetis Animal Health Pet Skin Disease Drugs Product
Table 74. Zoetis Animal Health Recent Developments/Updates
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Boehringer Ingelheim Pet Skin Disease Drugs Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Elanco Corporation Information
Table 81. Elanco Description and Business Overview
Table 82. Elanco Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Elanco Pet Skin Disease Drugs Product
Table 84. Elanco Recent Developments/Updates
Table 85. Virbac Corporation Information
Table 86. Virbac Description and Business Overview
Table 87. Virbac Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Virbac Pet Skin Disease Drugs Product
Table 89. Virbac Recent Developments/Updates
Table 90. Norbrook Laboratories Corporation Information
Table 91. Norbrook Laboratories Description and Business Overview
Table 92. Norbrook Laboratories Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Norbrook Laboratories Pet Skin Disease Drugs Product
Table 94. Norbrook Laboratories Recent Developments/Updates
Table 95. Dechra Veterinary Products Corporation Information
Table 96. Dechra Veterinary Products Description and Business Overview
Table 97. Dechra Veterinary Products Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Dechra Veterinary Products Pet Skin Disease Drugs Product
Table 99. Dechra Veterinary Products Recent Developments/Updates
Table 100. Vetoquinol Corporation Information
Table 101. Vetoquinol Description and Business Overview
Table 102. Vetoquinol Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Vetoquinol Pet Skin Disease Drugs Product
Table 104. Vetoquinol Recent Developments/Updates
Table 105. ALKINLAB Corporation Information
Table 106. ALKINLAB Description and Business Overview
Table 107. ALKINLAB Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. ALKINLAB Pet Skin Disease Drugs Product
Table 109. ALKINLAB Recent Developments/Updates
Table 110. Truseb Corporation Information
Table 111. Truseb Description and Business Overview
Table 112. Truseb Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Truseb Pet Skin Disease Drugs Product
Table 114. Truseb Recent Developments/Updates
Table 115. Olewo Corporation Information
Table 116. Olewo Description and Business Overview
Table 117. Olewo Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Olewo Pet Skin Disease Drugs Product
Table 119. Olewo Recent Developments/Updates
Table 120. KANGZHIBO Corporation Information
Table 121. KANGZHIBO Description and Business Overview
Table 122. KANGZHIBO Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. KANGZHIBO Pet Skin Disease Drugs Product
Table 124. KANGZHIBO Recent Developments/Updates
Table 125. Shanghai Hanvet Bio-Pharm Corporation Information
Table 126. Shanghai Hanvet Bio-Pharm Description and Business Overview
Table 127. Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Product
Table 129. Shanghai Hanvet Bio-Pharm Recent Developments/Updates
Table 130. DCVET Corporation Information
Table 131. DCVET Description and Business Overview
Table 132. DCVET Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. DCVET Pet Skin Disease Drugs Product
Table 134. DCVET Recent Developments/Updates
Table 135. Nanjing LANBOTO Corporation Information
Table 136. Nanjing LANBOTO Description and Business Overview
Table 137. Nanjing LANBOTO Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Nanjing LANBOTO Pet Skin Disease Drugs Product
Table 139. Nanjing LANBOTO Recent Developments/Updates
Table 140. Jindun Pharmaceutical Corporation Information
Table 141. Jindun Pharmaceutical Description and Business Overview
Table 142. Jindun Pharmaceutical Pet Skin Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Jindun Pharmaceutical Pet Skin Disease Drugs Product
Table 144. Jindun Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Pet Skin Disease Drugs Distributors List
Table 148. Pet Skin Disease Drugs Customers List
Table 149. Pet Skin Disease Drugs Market Trends
Table 150. Pet Skin Disease Drugs Market Drivers
Table 151. Pet Skin Disease Drugs Market Challenges
Table 152. Pet Skin Disease Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet Skin Disease Drugs
Figure 2. Global Pet Skin Disease Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Pet Skin Disease Drugs Market Share by Type in 2024 & 2034
Figure 4. Internal Medication Product Picture
Figure 5. External Medication Product Picture
Figure 6. Global Pet Skin Disease Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Pet Skin Disease Drugs Market Share by Application in 2024 & 2034
Figure 8. Parasitic Skin Diseases
Figure 9. Fungal Dermatoses
Figure 10. Bacterial Skin Diseases
Figure 11. Other
Figure 12. Global Pet Skin Disease Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Pet Skin Disease Drugs Market Size (2018-2034) & (US$ Million)
Figure 14. Global Pet Skin Disease Drugs Sales (2018-2034) & (K Units)
Figure 15. Global Pet Skin Disease Drugs Average Price (US$/Unit) & (2018-2034)
Figure 16. Pet Skin Disease Drugs Report Years Considered
Figure 17. Pet Skin Disease Drugs Sales Share by Manufacturers in 2024
Figure 18. Global Pet Skin Disease Drugs Revenue Share by Manufacturers in 2024
Figure 19. The Global 5 and 10 Largest Pet Skin Disease Drugs Players: Market Share by Revenue in 2024
Figure 20. Pet Skin Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 21. Global Pet Skin Disease Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 22. North America Pet Skin Disease Drugs Sales Market Share by Country (2018-2034)
Figure 23. North America Pet Skin Disease Drugs Revenue Market Share by Country (2018-2034)
Figure 24. United States Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Pet Skin Disease Drugs Sales Market Share by Country (2018-2034)
Figure 27. Europe Pet Skin Disease Drugs Revenue Market Share by Country (2018-2034)
Figure 28. Germany Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Pet Skin Disease Drugs Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Pet Skin Disease Drugs Revenue Market Share by Region (2018-2034)
Figure 35. China Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. China Taiwan Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Pet Skin Disease Drugs Sales Market Share by Country (2018-2034)
Figure 45. Latin America Pet Skin Disease Drugs Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Pet Skin Disease Drugs Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Pet Skin Disease Drugs Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Pet Skin Disease Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Pet Skin Disease Drugs by Type (2018-2034)
Figure 55. Global Revenue Market Share of Pet Skin Disease Drugs by Type (2018-2034)
Figure 56. Global Pet Skin Disease Drugs Price (US$/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Pet Skin Disease Drugs by Application (2018-2034)
Figure 58. Global Revenue Market Share of Pet Skin Disease Drugs by Application (2018-2034)
Figure 59. Global Pet Skin Disease Drugs Price (US$/Unit) by Application (2018-2034)
Figure 60. Pet Skin Disease Drugs Value Chain
Figure 61. Pet Skin Disease Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed